(Bloomberg) -- Novo Nordisk A/S, the maker of Ozempic and Wegovy, lost an office building at its Danish headquarters complex due to a massive fire, in the second blaze to hit the drugmaker in less ...

The Danish pharmaceutical company behind obesity drug Wegovy, Novo Nordisk, plans to invest US$1.09bn in expanding its ...

Danish drugmaker Novo Nordisk has been affected by a third fire in a month, the latest involving an office building near its Copenhagen headquarters. The latest fire started at a three-storey ...

(Bloomberg) -- Novo Nordisk A/S has halted roof repairs across ... 16 appears to be unrelated to this week’s blaze at Novo’s headquarters outside Copenhagen. “We will not make any roof ...

Headquarters of pharmaceutical company Novo Nordisk in Copenhagen, Denmark, on Sept. 26, 2023. (Tom Little/File photo / Reuters Photos) In the latest trial that spanned 68 weeks, 61.9% of patients ...

HYDERABAD, April 7 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new ... that Novo's India team had been pushing the global headquarters for an early Wegovy launch.